Yogan Patel, Partner at MHA, a UK member of Baker Tilly International, draws on an international network to provide insights into how the UK start-up landscape is changing.
Chris Whitehouse, a political consultant and expert on medical technology policy and regulation at Whitehouse Communications, highlights a new strand of the Department of Health and Social Care that will help drive developments in the MedTech sector.
Kevin Brownsill, Head of Technical: Learning and Development at adhesives supplier Intertronics, discusses common issues with industrial mixing in medical device applications, and explains how to address them.
Owen Mumford’s Head of Insight Alex Fong, and Business Development Manager Olivia Houselander speak on how to clear a path to sustainable single-use drug delivery devices.
Paul Hardman, Managing Consultant for Product Chemistry at vape compliance and regulatory specialist Broughton, explains the route manufacturers can take to develop NGPs as approved medical devices in the UK.
Michael King, Senior Director, Product & Strategy, Technology Solutions at IQVIA talks about the future of quality and regulatory in the MedTech industry.
Utilising technology developed at NASA, medical device start-up Torramics is developing the nanoPatch, an automated drug delivery system, which the company says is the world’s smallest and most precise drug delivery wearable device.
Stuart Powell, global head of product at Kallik, discusses the potential challenges associated with integrating software into a business’ pre-existing digital ecosystem, and the importance of interoperability.
